Skip to main content
main-content
Literatur
1.
Zurück zum Zitat Ge J, Pletcher MJ, Lai JC. N3C consortium. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: A national COVID cohort collaborative study. Gastroenterology 2021;161:1487–1501. CrossRef Ge J, Pletcher MJ, Lai JC. N3C consortium. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: A national COVID cohort collaborative study. Gastroenterology 2021;161:1487–1501. CrossRef
2.
Zurück zum Zitat John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D et al. Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021;181:1306–1314. CrossRef John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D et al. Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021;181:1306–1314. CrossRef
6.
Zurück zum Zitat Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer L, Hoffmann A, Fischer L, Addo MM, Lütgehetmann M, Lohse AW, Schulze ZurWiesch J, Sterneck M. SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients. Clin Gastroenterol Hepatol. 2022;20:162–172. https://​doi.​org/​10.​1016/​j.​cgh.​2021.​09.​003. CrossRefPubMed Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer L, Hoffmann A, Fischer L, Addo MM, Lütgehetmann M, Lohse AW, Schulze ZurWiesch J, Sterneck M. SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients. Clin Gastroenterol Hepatol. 2022;20:162–172. https://​doi.​org/​10.​1016/​j.​cgh.​2021.​09.​003. CrossRefPubMed
9.
Zurück zum Zitat John BV, Barritt AS, Moon A, Taddei TH, Kaplan DE. Dahman B (2022) Contributors as part of the VOCAL COVID-19 investigators, Doshi A, Deng Y, Mansour N, Ioannou G, Martin P, Chao HH Effectiveness of COVID-19 viral vector Ad.26.COV2.S vaccine and comparison with mRNA vaccines in Cirrhosis. Clin Gastroenterol Hepatol. 2022;S1542–3565:00566–00573. https://​doi.​org/​10.​1016/​j.​cgh.​2022.​05.​038. CrossRef John BV, Barritt AS, Moon A, Taddei TH, Kaplan DE. Dahman B (2022) Contributors as part of the VOCAL COVID-19 investigators, Doshi A, Deng Y, Mansour N, Ioannou G, Martin P, Chao HH Effectiveness of COVID-19 viral vector Ad.26.COV2.S vaccine and comparison with mRNA vaccines in Cirrhosis. Clin Gastroenterol Hepatol. 2022;S1542–3565:00566–00573. https://​doi.​org/​10.​1016/​j.​cgh.​2022.​05.​038. CrossRef
Metadaten
Titel
Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis
verfasst von
Raphaella D. Ferreira
Binu V. John
Publikationsdatum
10.08.2022
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Digestive Diseases and Sciences
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07644-z

Corona-Update

Die aktuelle Entwicklung im Überblick: Nachrichten, Webinare, Übersichtsarbeiten.